Skip to content

TMDX

TransMedics Group, Inc.

NASDAQ · Healthcare · Medical - Devices · US

$89.98
+3.45%
Ask drillr
0
Insider buys (3m)
1
Insider sells (3m)
-$722.4K
Net value (3m)
+25.8%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 14, 2026Hernandez Gerardo · officer: Chief Financial OfficerA-Award17,246$0.00
Jul 14, 2026Corcoran Nicholas · officer: See remarksA-Award11,727$0.00
Jul 14, 2026Hernandez Gerardo · officer: Chief Financial OfficerA-Award26,153$71
Jul 14, 2026Corcoran Nicholas · officer: See remarksA-Award17,784$71
Jul 14, 2026Hassanein Waleed H · director, officer: President & CEOA-Award49,669$0.00
Jul 14, 2026Hassanein Waleed H · director, officer: President & CEOA-Award112,984$71
Jun 17, 2026Gunderson Thomas J. · directorM-Exempt19,285$2.21
Jun 17, 2026Gunderson Thomas J. · directorSale9,624$75
May 22, 2026Basile Edward M · directorA-Award2,922$0.00
May 22, 2026Lovell Stephanie · directorA-Award2,922$0.00
May 22, 2026Kania Edwin · directorA-Award2,922$0.00
May 22, 2026RAINES MERILEE · directorA-Award2,922$0.00
May 22, 2026Gunderson Thomas J. · directorA-Award2,922$0.00
May 22, 2026TOBIN JAMES R · directorA-Award2,922$0.00
May 22, 2026Weill David · directorA-Award2,922$0.00
May 21, 2026Forsyth Matthew S. · officer: See RemarksA-Award23,171$66
May 21, 2026Forsyth Matthew S. · officer: See RemarksA-Award15,409$0.00
Mar 6, 2026Weill David · directorM-Exempt3,571$14
Mar 6, 2026Lovell Stephanie · directorSale1,193$150
Mar 6, 2026Weill David · directorSale3,571$147
Mar 4, 2026Corcoran Nicholas · officer: See remarksF-InKind984$135
Mar 4, 2026Hernandez Gerardo · officer: Chief Financial OfficerSale375$139
Mar 4, 2026Hernandez Gerardo · officer: Chief Financial OfficerM-Exempt1,324$77
Mar 4, 2026Corcoran Nicholas · officer: See remarksSale2,966$139
Mar 4, 2026Ranganath Anil P. · officer: See remarksSale864$139
Mar 4, 2026Hernandez Gerardo · officer: Chief Financial OfficerSale5,912$147
Mar 4, 2026Hernandez Gerardo · officer: Chief Financial OfficerM-Exempt5,912$70
Feb 20, 2026Cecere Giovanni · officer: Chief Commercial OfficerA-Award11,082$0.00
Feb 20, 2026Cecere Giovanni · officer: Chief Commercial OfficerA-Award16,734$136
Dec 5, 2025Weill David · directorM-Exempt5,000$14
Institutional positioning

13F filings over the trailing two quarters

New 134Increased 293Reduced 269Sold out 104
FilerActionSharesFiled
BlackRock, Inc.Increased5,596,549Aug 7, 2026
BLACKROCK, INC.Reduced5,293,331May 13, 2026
FMR LLCIncreased5,133,328Aug 13, 2026
FMR LLCIncreased5,096,243May 15, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCIncreased1,933,989Aug 13, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position1,919,535May 8, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased1,497,600Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position1,478,152May 15, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPIncreased1,442,098Aug 14, 2026
STATE STREET CORPIncreased1,420,421Aug 7, 2026
CITADEL ADVISORS LLCIncreased1,417,224Sep 2, 2026
STATE STREET CORPIncreased1,319,479May 15, 2026
INVESCO LTD.Increased1,037,974May 12, 2026
GOLDMAN SACHS GROUP INCIncreased965,931Mar 25, 2026
UBS ASSET MANAGEMENT AMERICAS INCReduced939,523May 13, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 14, 2026